Combination of the Immune Modulator Dimethyl Fumarate With Intraarterial Treatment in Acute Ischemic Stroke

NCT04891497 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped There are no suitable patients

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Dimethyl Fumarate
DRUG: Placebo

Sponsor

Xuanwu Hospital, Beijing